Hyposensitization and desensitization in allergic contact dermatitis

Area of Science:

• Dermatology
• Immunology
• Allergology

Background:

• Acquired allergic contact dermatitis (ACD) causes significant morbidity and socioeconomic effects.
• Occupational exposures and skin barrier damage are key risk factors for ACD.
• ACD is challenging to manage, especially when allergen exposure is unavoidable.

Purpose of the Study:

• To evaluate the efficacy of intradermal steroid injections in achieving specific antigen hyposensitization.
• To assess the impact of weekly injections into shifted patch-test sites.

Main Methods:

• Prospective, open-label study involving 10 patients with ACD.
• Weekly patch testing with known allergens, followed by intradermal triamcinolone injection at the test site.
• Outcomes measured included clinical score, reaction size, erythema, and thermal characteristics.

Main Results:

• Significant reduction in patch-test reactions observed.
• Improvements in clinical scores, decreased reaction sizes, and reduced heat production were noted.
• Three patients achieved negative patch tests, with desensitization lasting 2-4 months.

Conclusions:

• Weekly intradermal steroid injections at positive patch-test sites show a trend towards allergen-specific hyposensitivity.
• Some patients developed nonreactivity to repeat patch testing.
• This approach may offer a novel strategy for managing ACD.